A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 420 participants.
Also called NCT01518998
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 420 participants
- Sponsor
- Asan Medical Center
- Boryung Pharmaceutical Co., Ltd
- Chonnam National University Hospital
- Daegu Catholic University Medical Center
- DongGuk University
- Gachon University Gil Medical Center
- Hanyang University Seoul Hospital
- Inha University Hospital
- Inje University
- Jeju National University Hospital
- Kangbuk Samsung Hospital
- Korea University Guro Hospital
- Kyungpook National University Hospital
- Pusan National University Yangsan Hospital
- Samsung Medical Center
- Seoul National University Bundang Hospital
- Seoul National University Hospital
- The Catholic University of Korea
- Wonju Severance Christian Hospital
- Wonkwang University Hospital
- Yeungnam University Hospital
- Registry
-
NCT01518998
-
- Other papers using this trial's data
- A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01518998. Randomized; double masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2013-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- Fimasartan , Amlodipine, Placebo
- Lead sponsor
- Boryung Pharmaceutical Co., Ltd
- Collaborator
- Gachon University Gil Medical Center
- Collaborator
- The Catholic University of Korea
- Collaborator
- Kyungpook National University Hospital
- Collaborator
- Daegu Catholic University Medical Center
- Collaborator
- Wonkwang University Hospital
- Collaborator
- Wonju Severance Christian Hospital
- Collaborator
- Korea University Guro Hospital
- Collaborator
- DongGuk University
- Collaborator
- Yeungnam University Hospital
- Collaborator
- Chonnam National University Hospital
- Collaborator
- Cheil General Hospital and Women's Healthcare Center
- Collaborator
- Chungnam National University
- Collaborator
- Asan Medical Center
- Collaborator
- Seoul National University Bundang Hospital
- Collaborator
- Inha University Hospital
- Collaborator
- Seoul National University Hospital
- Collaborator
- Inje University
- Collaborator
- Samsung Medical Center
- Collaborator
- Pusan National University Yangsan Hospital
- Collaborator
- Soon Chun Hyang University
- Collaborator
- Catholic University of Korea Saint Paul's Hospital
- Collaborator
- Hallym University Kangnam Sacred Heart Hospital
- Collaborator
- Jeju National University Hospital
- Collaborator
- Hanyang University Seoul Hospital
- Collaborator
- Kangbuk Samsung Hospital
Registry records
Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry organizations 21
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 28 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 23 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 19 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 13 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
Record details
- Record id
cardio:ct-nct01518998- Content hash
32a940973b284771ab62bc600e92dadd9db04004038161605d69ba983e280db7